arrow
返回
S

Sheila M. Galloway

merck & company

45H指数
150论文数
7.4K被引数
收录论文 12
发表时间
Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromides
err2018-04-01
err39
PREAI
errBercu, J. P.; Galloway, S. M.; Parris, P.; Teasdale, A.; Masuda-Herrera, M.; Dobo, K.; Heard, P.; Kenyon, M.; Nicolette, J.; Vock, E.; Ku, W.; Harvey, J.; White, A.; Glowienke, S.; Martin, E. A.; Custer, L.; Jolly, R. A.; Thybaud, V.
err分享
err收藏
OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based Therapeutics
err2016-04-01
err33
PREAI
errBerman, Cindy L.; Barros, Scott A.; Galloway, Sheila M.; Kasper, Peter; Oleson, Frederick B.; Priestley, Catherine C.; Sweder, Kevin S.; Schlosser, Michael J.; Sobol, Zhanna
err分享
err收藏
Overcoming Mutagenicity and Ion Channel Activity: Optimization of Selective Spleen Tyrosine Kinase Inhibitors
err2015-02-16
err23
PREAI
errEllis, J. Michael; Altman, Michael D.; Bass, Alan; Butcher, John W.; Byford, Alan J.; Donofrio, Anthony; Galloway, Sheila; Haidle, Andrew M.; Jewell, James; Kelly, Nancy; Leccese, Erica K.; Lee, Sandra; Maddess, Matthew; Miller, J. Richard; Moy, Lily Y.; Osimboni, Ekundayo; Otte, Riau D.; Reddy, M. Vijay; Spencer, Kerrie; Sun, Binyuan; Vincent, Stella H.; Ward, Gwendolyn J.; Woo, Grace H. C.; Yang, Chiming; Houshyar, Hani; Northrup, Alan B.
err分享
err收藏
Bacterial mutagenicity screening in the pharmaceutical industry (vol 752, pg 99, 2013)
err2013-10-01
err0
errOAAI
errEscobar, P. A.; Kemper, R. A.; Tarca, J.; Nicolette, J.; Kenyon, M.; Glowienke, S.; Sawant, S. G.; Christensen, J.; Johnson, T. E.; McKnight, C.; Ward, G.; Galloway, S. M.; Custer, L.; Gocke, E.; O'Donovan, M. R.; Braun, K.; Snyder, R. D.; Mahadevan, B.
err分享
err收藏
Bacterial mutagenicity screening in the pharmaceutical industry
err2013-04-01
err50
PREAI
errEscobar, P. A.; Kemper, R. A.; Tarca, J.; Nicolette, J.; Kenyon, M.; Glowienke, S.; Sawant, S. G.; Christensen, J.; Johnson, T. E.; McKnight, C.; Ward, G.; Galloway, S. M.; Custer, L.; Gocke, E.; O'Donovan, M. R.; Braun, K.; Snyder, R. D.; Mahadevan, B.
err分享
err收藏
Strategy for genotoxicity testing:: Hazard identification and risk assessment in relation to in vitro testing
err2007-02-01
err104
PREAI
errThybaud, V.; Aardema, M.; Clements, J.; Dearfield, K.; Galloway, S.; Hayashi, M.; Jacobson-Kram, D.; Kirkland, D.; MacGregor, J. T.; Marzin, D.; Ohyama, W.; Schuler, M.; Suzuki, H.; Zeiger, E.
err分享
err收藏
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
err2006-04-01
err397
PREAI
errMüller, L; Mauthe, RJ; Riley, CM; Andino, MM; De Antonis, D; Beels, C; DeGeorge, J; De Knaep, AGM; Ellison, D; Fagerland, JA; Frank, R; Fritschel, B; Galloway, S; Harpur, E; Humfrey, CDN; Jacks, AS; Jagota, N; Mackinnon, J; Mohan, G; Ness, DK; O'Donovan, MR; Smith, MD; Vudathala, G; Yotti, L
err分享
err收藏
Proceedings of a workshop on DNA adducts: Biological significance and applications to risk assessment Washington, DC, April 13-14, 2004
err2005-10-01
err34
PREAI
errSander, M; Cadet, J; Casciano, DA; Galloway, SM; Marnett, LJ; Novak, RF; Pettit, SD; Preston, RJ; Skare, JA; Williams, GM; Van Houten, B; Gollapudi, BB
err分享
err收藏
Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replication
err2005-02-01
err67
PREAI
errPrakash, TP; Prhavc, M; Eldrup, AB; Cook, PD; Carroll, SS; Olsen, DB; Stahlhut, MW; Tomassini, JE; MacCoss, M; Galloway, SM; Hilliard, C; Bhat, B
err分享
err收藏
Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster
err2000-02-01
err245
errOAAI
errBai, C; Connolly, B; Metzker, ML; Hilliard, CA; Liu, XM; Sandig, V; Soderman, A; Galloway, SM; Liu, QY; Austin, CP; Caskey, CT
err分享
err收藏